Table 1 Primary cancer characteristics and pre-existing disease of patients at baseline
From: Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
| Variable | Patients [cases (%)] |
|---|---|
| Total | 527 |
| Male | 348 (66.0) |
| Primary cancer | |
| Colorectal | 378 (71.7) |
| Gastric | 123 (23.3) |
| Head and neck | 15 (2.9) |
| Esophageal | 6 (1.1) |
| Breast | 4 (0.8) |
| Nasopharyngeal | 1 (0.2) |
| Cancer stage | |
| I | 2 (0.4) |
| II | 105 (20.0) |
| III | 249 (47.2) |
| IV | 153 (29.0) |
| Not available | 18 (3.4) |
| Pre-existing disease | |
| Hypertension | 106 (20.1) |
| Diabetes | 29 (5.5) |
| Cardiac disease | 13 (2.5) |
| Hyperlipidemia | 4 (0.8) |
| Surgical history | 415 (78.7) |
| Radical | 338 (64.1) |
| Palliative | 57 (10.8) |
| Unknown | 20 (3.8) |
| Treatment history | 176 (33.4) |
| Chemotherapy | 118 (22.4) |
| Radiotherapy | 32 (6.1) |
| Chemotherapy and radiotherapy | 26 (4.9) |